COVID-19: The Eight Obstacles Ahead

There is great news on the COVID-19 vaccine front. Scientists and pharmaceutical companies have developed a series of safe and effective vaccines in record time. The Food and Drug Administration (FDA) approved Pfizer’s COVID-19 vaccine last Friday, with Moderna’s likely to follow this week. Other vaccines are in the pipeline. Do these vaccines signal the beginning of the end of the pandemic? Perhaps, but there are many obstacles.

Obstacle #1: Skyrocketing Numbers
COVID-19 is out of control. An American dies of COVID-19 every 35 seconds. We are experiencing the equivalent of another 9/11 every day. Some 300,000 Americans have died from the coronavirus in the past nine months. In the past six weeks, hospitalizations have more than doubled. There are currently more than 100,000 patients hospitalized with the coronavirus, leading to a shortage of hospital beds. More importantly, as numbers soar, hospitals are running out of nurses, doctors, and other healthcare workers.

Obstacle #2: Disease Denial
Last week, a congressman-elect from Virginia called COVID-19 a “phony pandemic.” A fall survey showed that half of all Republicans and a quarter of all Democrats say the coronavirus is no more serious than the flu. There are multiple reports from nurses about patients on their death beds still denying that they had COVID-19. People who believe that it’s a phony pandemic are less likely to listen to the disease prevention recommendations of our public health experts or consider getting a vaccine.

Obstacle #3: COVID Fatigue
It has been nine months since the start of the pandemic. Americans are understandably tired of the isolation, the economic devastation, the total disruption of normalcy, and wearing masks. People are understandably getting sloppy with observing preventive measures. Even worse, some ignore rules and recommendations restricting large gatherings and social distancing. Many young adults have simply had enough. COVID fatigue has been blamed for the high volume of Thanksgiving holiday travel, despite the advice of the Centers for Disease Control and Prevention (CDC) to avoid it.

Obstacle #4: Anti-maskers
Many Americans refuse to wear masks. They claim that the request to wear a mask is an infringement of their personal freedom. There have been “no-mask protests” in a number of states. At a time when they had more coronavirus infections than any other state, North Dakota had a mask-wearing rate of less than 50 percent. President-elect Biden is recommending a 100-day mask mandate after his inauguration. Mask compliance will greatly impact the duration and severity of this pandemic.

Obstacle #5: Ineffective Therapeutics
There is no “magic bullet” that cures COVID-19. Treatment is primarily supportive care focusing on the delivery of supplemental oxygen. Dexamethasone, a steroid, is the only medication that scientific evidence shows improves survival, and it’s only beneficial in patients with severe disease. None of the other medications reduce deaths, and hydroxychloroquine actually appears to be harmful. The antiviral agent Remdesivir is currently the only drug that is approved by the Food and Drug Administration (FDA) for treatment, and three weeks ago the World Health Organization (WHO) stopped recommending it because it has “no important effect” on survival.

Antibody cocktails, like the Regeneron product that President Trump was given in October, show some promise, but Emergency Use Authorization (EUA) isn’t the same as evidence-based efficacy. As of now, these new treatments are still too expensive and are generally unavailable unless you are a VIP.

Obstacle #6: Vaccine Availability
There is limited early production and a two-dose requirement, along with distribution and storage challenges, for both the Pfizer and Moderna products. Immunization of front-line health care workers and elderly living in long-term care facilities commences this week, but it could be more than six months until a vaccine is available for all Americans.

Obstacle #7: Vaccine Acceptance
The success of a vaccination program is contingent upon the public’s willingness to get vaccinated. Even after excluding the anti-vaxxers, polls show that many Americans are hesitant to take it. They are distrustful of the both the speed of development and the politicization of the process. Annual flu vaccination rates are usually less than 50 percent. That percentage for COVID-19 will be too low to reach herd immunity, which is the presence of enough immune individuals in the population, or 70 percent of all Americans receiving a vaccine. Government officials and celebrities will have to lead by example and get vaccinated to help promote confidence and broaden public support of the vaccines.

Obstacle #8: Vaccine Unknowns
There are many vaccine questions. Duration is the biggest one. How long will they provide protection? A month? six months? A year? Longer? Will we need booster shots to stay protected?

Will vaccines prevent transmission after virus exposure, or will they primarily reduce disease severity? We don’t know. It still may be possible to transmit COVID-19 after being vaccinated.

Are vaccines safe for everybody, especially young children and pregnant women, who have not been included in any of the vaccine trials? These groups may be among the last to be offered immunization. Of note, last week a few people vaccinated in the United Kingdom with the Pfizer product had dangerous allergic reactions, so individuals with a past history of severe allergies will also likely need to wait for new vaccines and additional scientific studies.

Are we at the beginning of the end of the pandemic? The end will be when we reach herd immunity. When depends on us: our willingness is to look at the data and acknowledge that COVID-19 is real. Our willingness to listen to our public health experts and avoid large gatherings, (especially around the upcoming holidays), maintain physical distancing of at least six feet, wash our hands regularly; and get vaccinated. And most important is our willingness to wear masks until we reach herd immunity. If we don’t willingly take these steps, despite the excitement and promise of COVID-19 vaccines, there will be a whole lot of hurt well into 2021.

Facebook
Twitter
LinkedIn

Related Stories

Where is the OCR?

The articles describe a significant 2026 dispute over the misuse of health information exchanged by asserting a treatment purpose through Carequality. (Raths) The core allegation

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Trending News

Featured Webcasts

Ask Dr. Hirsch: Clarifying Medicare’s Most Misunderstood Rules – Part 2

Medicare regulations are complex and even seasoned professionals struggle to apply them consistently. Due to overwhelming demand, Dr. Hirsch returns for Part 2 of Ask Dr. Hirsch: Clarifying Medicare’s Most Misunderstood Rules to answer even more of Medicare’s most misunderstood questions, covering inpatient status, observation, SNF access, Medicare Advantage denials, and more. Join Dr. Hirsch as he provides clear, referenced answers to real-world questions submitted by your peers, helping you navigate Medicare compliance with confidence and clarity.

June 18, 2026

Reengineering Utilization Management: Building an Adaptive Model for the New Payer Era

Traditional utilization management models can no longer keep pace with regulatory shifts, payer scrutiny, and operational pressures. In this webcast, Tiffany Ferguson, LMSW, CMAC, ACM, ACPA-C, introduces an Adaptive Model strategy that modernizes UM through role specialization, technology-driven workflows, and proactive, team-based processes. Attendees will learn how to restructure programs to improve efficiency, strengthen clinical collaboration, and enhance financial performance in a rapidly changing healthcare environment.

May 20, 2026

Compliance for the Inpatient Psychiatric Facility (IPF-PPS): Minimizing Federal Audit Findings by Strengthening Best Practices

Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.

April 9, 2026

Mastering MDM for Accurate Professional Fee Coding

In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.

March 31, 2026

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26 at checkout

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24